Projects
ENRICH-AF - EdoxabaN foR IntraCranial Hemorrhage survivors with Atrial Fibrillation
Project Description
Background:
A prospective, randomized open-label, blinded end-point (PROBE), investigator-initiated, international study that will determine the efficacy and safety of edoxaban compared with standard of care (either no antithrombotic therapy or antiplatelet monotherapy) for stroke prevention in high-risk AF (CHA2DS2-VASc score ?2) patients and previous intracranial haemorrhage
Project Duration
2020 - Ongoing
Project Lead
Dr. Denis Xavier
Authors
PI: Dr. Denis Xavier, Co-I: Dr. Padmini Devi
Project Status
ongoing